- Home
- In Vitro Diagnostic Industry
- In Vitro Market and Forecasts, May 2012
Industries
- In Vitro Diagnostic (65)
- Diagnostics (31)
- Drug and Medication (26)
- Pathology (18)
- Drug Discovery and Development (15)
-
- Biological Therapy (12)
- Agriculture (11)
- Business Services (9)
- Fruit and Vegetable (8)
- Biotechnology (6)
- Advanced Material (4)
- Drug Delivery Technology (4)
- Energy & Environment (4)
- Genomics (4)
- Managed Care (4)
- Pharmaceutical (4)
- Medical Facility (3)
- Nanotechnology (3)
- Pesticide (3)
- Agricultural Products (2)
Top countries
Publication dates
All regions
-
- Belgium (2)
- Cyprus (1)
- Czech Republic (1)
- Denmark (2)
- Estonia (1)
- France (7)
- Germany (3)
- Ireland (7)
- Italy (2)
- Lithuania (2)
- Luxembourg (1)
- Netherlands (2)
- Norway (3)
- Poland (2)
- Portugal (1)
- Romania (2)
- Russian Federation (1)
- Slovakia (slovak Republic) (2)
- Spain (1)
- Sweden (3)
- Switzerland (4)
- United Kingdom (7)
-
- Australia (6)
- Belgium (2)
- Canada (11)
- Czech Republic (1)
- Denmark (2)
- Estonia (1)
- France (7)
- Germany (3)
- Ireland (7)
- Israel (3)
- Italy (2)
- Japan (7)
- Luxembourg (1)
- Netherlands (2)
- Norway (3)
- Poland (2)
- Portugal (1)
- Slovakia (2)
- South Korea (4)
- Spain (1)
- Sweden (3)
- Switzerland (4)
- Turkey (1)
- United Kingdom (7)
- United States (108)
In Vitro Market and Forecasts, May 2012
You might be interested in: cell culture, molecular diagnostic, tissue culture, more »
industry reports
company reports
Investor presentation: In Vitro Diagnostic for Year 2011
- Company report
- December 2011
- 28 pages
... To laboratory and point of care blood gas analysers measuring arterial blood in a clinical setting Proxima generation 2 achieved european ce marking in december 2011 as a patient dedicated in-vitro arterial ...
- Industries: In Vitro Diagnostic
The Czech Republic: Brief Overview, 2011, focus on In Vitro Diagnostic
- Country report
- March 2011
- 12 pages
- by Intergovernmental Agency
... Directive play a role in achieving an increased transparency in the pricing and reimbursement of innovative/personalised medicines associated with medical devices such as in- vitro diagnostics : no please ...
- Industries: In Vitro Diagnostic
- Countries: Czech Republic
Investor presentation: Diagnostics in China for Year 2011
- Company report
- March 2011
- 21 pages
... Developed market china 8% 75% developed market 25% 3 investment highlights: proven product dl tc biliti patient monitoring & life developmen apabilities pp support products in Vitro ...
- Industries: Diagnostics
- Countries: China, World
Investor presentation: Pathology for Year 2011
- Company report
- March 2011
- 12 pages
... To strengthen clinical development aspects pred. Pharmacology (in-vitro) pred. Pharmacology (in-vivo) biomarker discovery biomarker qualification clinical dev. & Patient ...
Cleveland BioLabs Inc. - Company Report for Year 2011
- Company report
- September 2011
- 3 pages
- by Corporation
... That have shown efficacy in-vitro and in-vivo with multiple pathogens, such as malaria, fungi, trypanosoma, and others. Antimycons, a series of inhibitors of the oncoprotein myc, one of the most universal ...
- Industries: Drug Discovery and Development
- Countries: United States, Russian Federation
Investor presentation: Diagnostics in China for Year 2011
- Company report
- March 2011
- 19 pages
- by Market Research Publisher
... Developed market 2 24% expending product offering patient monitoring & life support products in Vitro diagnostic products medical imaging systems pg pp oh lif d launch time immunoassay & reagent ...
- Industries: Diagnostics
- Countries: China
Arrayit Corp. - Company Report for Year 2011
- Company report
- December 2011
- 142 pages
... Regulations, and we may incur significant expenses to comply with, and experience delays in our product commercialization as a result of, these regulations. The fda must approve certain in-vitro diagnostic ...
- Industries: In Vitro Diagnostic
- Countries: United States
Investor presentation: Diagnostics in China for Year 2011
- Company report
- March 2011
- 17 pages
- by Market Research Publisher
... Focus on county level hospitals. These are mostly in the form of direct government funding to hospitals 9 10 2011 New products pipeline patient monitoring & life support products in Vitro ...
- Industries: Diagnostics
- Countries: China
Investor presentation: Diagnostics in The United States for Year 2011
- Company report
- March 2011
- 20 pages
... Fda feedback on advisory committee on further development and approval process in-vitro diagnostics redectane adc + csr rx dx third-party adc collaborations increase sales revenue ...
- Industries: Diagnostics
- Countries: United States
Investor presentation: Diagnostics in The United States for Year 2011
- Company report
- March 2011
- 24 pages
... And revenue fda feedback on advisory committee on further development and approval process in-vitro diagnostics redectane adc + csr rx dx third-party adc collaborations increase sales ...
- Industries: Diagnostics
- Countries: United States
» Purchase Premium Reports (From $ 640 - $ 3 600)
6 reports for In Vitro
In Vitro Diagnostics - A Global Market Overview
- $ 4 500
- Industry report
- May 2012
- by Industry Experts
... By european researchers- expression of genes- mrna detective- the major challengesingle-cell molecular 'fingerprints' for brain tumors generated using new diagnostic chipin vitro diagnostics ...
Reportlinker.com © Copyright 2012. All rights reserved
